Meeting
2022 ASCO Genitourinary Cancers Symposium
Identification of homologous recombination and repair (HRR) deficiency using circulating tumor DNA (ctDNA) in advanced prostate cancer (aPC).
Authors
Leslie A. Bucheit
Guardant Health, Redwood City, CA
Leslie A. Bucheit , Jennifer Yen , Leylah Drusbosky , Catalin Barbacioru , Sante Gnerre , Hao Wang , Alexander Artyomenko , Arielle Yabolonovitch , Yu Fu , Che-Yu Lee , Max Maliska , Elena Helman , Michael Dorshner , Martina Lefterova
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 180)
DOI
10.1200/JCO.2022.40.6_suppl.180
Abstract #
180
Poster Bd #
K1
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh
Poster
2021 ASCO Annual Meeting
Analysis of homologous recombination DNA repair gene mutation status in patients with metastatic small cell lung cancer treated with cediranib and olaparib on NCI 9881 study.
First Author: Joseph W. Kim
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2023 ASCO Annual Meeting
HRD signature and HRD genomic landscape of tumors from 896 patients with early-stage breast cancer (BC).
First Author: June Evelyn Jeon